Efficacy of combined intravenous immunoglobulins and steroids in children with primary immune thrombocytopenia and persistent bleeding symptoms

Blood Transfusion

Volumn 12, Issue 3, 2014, Pages 340-345

  Parodi, Emilia ^a,c   Giordano, Paola ^b   Rivetti, Elisa ^c   Giraudo, Maria Teresa ^c   Ansaldi, Giulia ^c   Davitto, Mirella ^c   Mondino, Anna ^c   Farruggia, Piero ^d   Amendola, Giovanni ^e   Matarese, Sofia M R ^f   Rossi, Francesca ^f   Russo, Giovanna ^g   Ramenghi, Ugo ^c  

^a MAURIZIANO HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Nephrology and Dialysis Unit   (Italy)

^e Umberto i Hospital   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF CATANIA   (Italy)

Author keywords

Children; ITP; IVIG; Primary immune thrombocytopenia; Steroids

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; GLUCOCORTICOID; IMMUNOLOGIC FACTOR;

ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLEEDING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GLUCOSURIA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MALE; REMISSION; THROMBOCYTE COUNT; TREATMENT RESPONSE; ADOLESCENT; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; DRUG COMBINATION; HEMORRHAGE; INFANT; MULTICENTER STUDY; PRESCHOOL CHILD; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HEMORRHAGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; MALE; METHYLPREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 84904691457     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2014.0185-13     Document Type: Article

References (10)

1. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113: 2386-93.
2. Eden OB, Lilleyman JS. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Arch Dis Child 1992; 67: 1056-8.
3. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40. (Pubitemid 26230668)
4. De Mattia D, Del Principe D, Del Vecchio GC, et al. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica. Haematologica 2000; 85: 420-4. (Pubitemid 30318517)
5. De Mattia D, Del Vecchio GC, Russo G, et al. Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines. Acta Haematol 2010; 123: 96-109.
6. Blanchette V, Imbach P, Andrew M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344: 703-7. (Pubitemid 24281420)
7. Kalpatthi R, Bussel JB. Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpura. Curr Opin Pediatr 2008; 20: 8-16.
8. Kühne T, Imbach P. Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions. Vox Sang 2013; 104: 55-66.
9. Kuhne T, Blanchette V, Buchanan GR, et al. Splenectomy in children with idiopathic thrombocytopenic purpura: a prospective study of 134 children from the Intercontinental Childhood ITP Study Group. Pediatr Blood Cancer 2007; 49: 829-34. (Pubitemid 47519522)
10. Jayabose S, Mahmoud M, Levendoglu-Tugal O, et al. Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura. J Pediatr Hematol Oncol 1999; 21: 514-7. (Pubitemid 30305986)